newsfilter
← Latest News
ACCESS Newswire·

Ainos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis (FCGS)

Open-Label Study Demonstrates Durable Reduction in Oral Inflammation with Favorable Tolerability Profile at Interim AnalysisHOUSTON, TEXAS / ACCESS Newswire / February 17, 2026 / Ainos, Inc.